Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2001 Apr;54(4):317–320. doi: 10.1136/jcp.54.4.317

Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia?

L Chan 1, S Ma 1, A Chan 1, S Ha 1, J Waye 1, Y Lau 1, D Chui 1
PMCID: PMC1731396  PMID: 11304851

Abstract

Aims—To investigate whether it is worthwhile, in areas where thalassaemia is common, to screen for globin gene mutations in subjects with a mean corpuscular volume (MCV) above 80 fL, especially in partners of known thalassaemia carriers.

Methods—Blood samples from 95 subjects with MCV between 80 and 85 fL were screened for the presence of α globin gene mutations and the haemoglobin (Hb) E mutation.

Results—Thirty four subjects harboured globin gene mutations. Of these, 31 had deletions of one α globin gene, one had Hb Constant Spring, and three had Hb E mutations.

Conclusion—Based on the above figures and known prevalence rates of thalassaemia carriers, it would seem worthwhile to screen for globin gene mutations in partners of known thalassaemia carriers, regardless of MCV, to identify pregnancies at risk of Hb H disease or Hb E/ß thalassaemia.

Key Words: thalassaemia • globin gene mutation • mean corpuscular volume • screening • genetic counselling

Full Text

The Full Text of this article is available as a PDF (185.3 KB).

graphic file with name 99296.f1.jpg

Open in a new tab

Figure 1 The distribution of 2640 subjects according to their erythrocyte mean corpuscular volume (MCV) at 2 fL intervals.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baysal E., Huisman T. H. Detection of common deletional alpha-thalassemia-2 determinants by PCR. Am J Hematol. 1994 Jul;46(3):208–213. doi: 10.1002/ajh.2830460309. [DOI] [PubMed] [Google Scholar]
  2. Cao A. 1993 William Allan award address. Am J Hum Genet. 1994 Mar;54(3):397–402. [PMC free article] [PubMed] [Google Scholar]
  3. Chan A. Y., So C. K., Chan L. C. Comparison of the HbH inclusion test and a PCR test in routine screening for alpha thalassaemia in Hong Kong. J Clin Pathol. 1996 May;49(5):411–413. doi: 10.1136/jcp.49.5.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chan V., Chan T. K., Liang S. T., Ghosh A., Kan Y. W., Todd D. Hydrops fetalis due to an unusual form of Hb H disease. Blood. 1985 Jul;66(1):224–228. [PubMed] [Google Scholar]
  5. Chan V., Chan V. W., Tang M., Lau K., Todd D., Chan T. K. Molecular defects in Hb H hydrops fetalis. Br J Haematol. 1997 Feb;96(2):224–228. doi: 10.1046/j.1365-2141.1997.d01-2017.x. [DOI] [PubMed] [Google Scholar]
  6. Chan V., Yam I., Chen F. E., Chan T. K. A reverse dot-blot method for rapid detection of non-deletion alpha thalassaemia. Br J Haematol. 1999 Mar;104(3):513–515. doi: 10.1046/j.1365-2141.1999.01221.x. [DOI] [PubMed] [Google Scholar]
  7. Chen F. E., Ooi C., Ha S. Y., Cheung B. M., Todd D., Liang R., Chan T. K., Chan V. Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med. 2000 Aug 24;343(8):544–550. doi: 10.1056/NEJM200008243430804. [DOI] [PubMed] [Google Scholar]
  8. Dodé C., Rochette J., Krishnamoorthy R. Locus assignment of human alpha globin mutations by selective amplification and direct sequencing. Br J Haematol. 1990 Oct;76(2):275–281. doi: 10.1111/j.1365-2141.1990.tb07884.x. [DOI] [PubMed] [Google Scholar]
  9. Fairbanks V. F., Gilchrist G. S., Brimhall B., Jereb J. A., Goldston E. C. Hemoglobin E trait reexamined: a cause of microcytosis and erythrocytosis. Blood. 1979 Jan;53(1):109–115. [PubMed] [Google Scholar]
  10. Fucharoen S., Winichagoon P., Thonglairuam V. Beta-thalassemia associated with alpha-thalassemia in Thailand. Hemoglobin. 1988;12(5-6):581–592. doi: 10.3109/03630268808991648. [DOI] [PubMed] [Google Scholar]
  11. Higgs D. R. alpha-Thalassaemia. Baillieres Clin Haematol. 1993 Mar;6(1):117–150. doi: 10.1016/s0950-3536(05)80068-x. [DOI] [PubMed] [Google Scholar]
  12. Lau Y. L., Chan L. C., Chan Y. Y., Ha S. Y., Yeung C. Y., Waye J. S., Chui D. H. Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong -- implications for population screening. N Engl J Med. 1997 May 1;336(18):1298–1301. doi: 10.1056/NEJM199705013361805. [DOI] [PubMed] [Google Scholar]
  13. Modell B., Kuliev A. M. A scientific basis for cost-benefit analysis of genetics services. Trends Genet. 1993 Feb;9(2):46–52. doi: 10.1016/0168-9525(93)90186-L. [DOI] [PubMed] [Google Scholar]
  14. Modell M., Modell B. Genetic screening for ethnic minorities. BMJ. 1990 Jun 30;300(6741):1702–1704. doi: 10.1136/bmj.300.6741.1702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rogers M., Phelan L., Bain B. Screening criteria for beta thalassaemia trait in pregnant women. J Clin Pathol. 1995 Nov;48(11):1054–1056. doi: 10.1136/jcp.48.11.1054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Thein S. L. beta-Thalassaemia. Baillieres Clin Haematol. 1993 Mar;6(1):151–175. doi: 10.1016/s0950-3536(05)80069-1. [DOI] [PubMed] [Google Scholar]
  17. Trent R. J., Wilkinson T., Yakas J., Carter J., Lammi A., Kronenberg H. Molecular defects in 2 examples of severe Hb H disease. Scand J Haematol. 1986 Mar;36(3):272–279. doi: 10.1111/j.1600-0609.1986.tb01734.x. [DOI] [PubMed] [Google Scholar]
  18. Waye J. S., Eng B., Patterson M., Chui D. H., Olivieri N. F. Identification of a novel termination codon mutation (TAA-->TAT, Term-->Tyr) in the alpha 2 globin gene of a Laotian girl with hemoglobin H disease. Blood. 1994 Jun 1;83(11):3418–3420. [PubMed] [Google Scholar]
  19. Zhao J. B., Zhao L., Gu Y. C., Huisman T. H. Types of alpha-globin gene deficiencies in Chinese newborn babies in the Guangxi region, P. R. China. Hemoglobin. 1992;16(4):325–328. doi: 10.3109/03630269208998877. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES